Beijing Fangsheng Investment Management Center

Fang Fund Partners, established in 2011 and based in Beijing, China, is a venture capital firm that specializes in early and growth stage investments. The firm focuses on innovative sectors including big data, artificial intelligence, smart technology, healthcare, new energy, and fintech. With a management team that possesses extensive experience in business practices and venture investment, Fang Fund Partners aims to provide value-added services to its portfolio companies. This includes support in areas such as capital, marketing strategies, and industry cooperation. The firm is committed to fostering entrepreneurship and social progress by aligning with quality resources and the ecological industry chain, while also leveraging its international perspective to enhance the strategic development of invested companies.

Dong Zheng

Partner

36 past transactions

SuperC

Venture Round in 2023
SuperC is a company founded in 2012 and based in Dongguan City, Guangdong, China, specializing in the research and production of innovative nanomaterials. It develops Few Layer Graphenes (FLG), which are utilized in a variety of applications, including lithium-ion batteries, fireproof coatings, anticorrosive coatings, and materials that enhance electrical and thermal conductivity. Through its focus on advanced nanotechnology, SuperC aims to contribute to sectors that require high-performance materials, positioning itself as a key player in the nanomaterials market.

BioAntibody

Series A in 2023
BioAntibody is a biotechnology company focused on the research and development of antigens, antibodies, and downstream detection reagents for diagnostic and therapeutic applications. The firm specializes in creating core raw materials intended for in vitro diagnostics and biopharmaceuticals. Utilizing innovative high-efficiency targeted hybridoma cell fusion technology, BioAntibody supports stable cell growth and high-throughput screening across various medical categories, including cardiovascular, cerebrovascular, inflammation, infectious diseases, tumors, and hormones. By providing high-quality raw materials, the company aims to enhance disease detection and improve therapeutic outcomes for its customers.

Baikang Bio

Series A in 2023
Baikang Bio is a tech biotechnology firm specializing in the research and development of antigens, antibodies, and downstream detection reagents for diagnosis and therapy. The product pipelines cover cardiovascular and cerebrovascular, inflammation, infectious diseases, tumors, hormones, and other categories, from raw materials to finished goods. They are dedicated to innovation and providing their customers with solutions. They could contribute to human ecology and health.

Boaoxin

Series B in 2022
Biosion is a biotech company focused on the development of biologics to treat resistant, relapsed, residual immune, and oncologic diseases.

Easy Chat Technology

Series B in 2022
YiLiao Technology has focused on the online customer-acquiring AI intelligent customer service robot track, serving the "conversation-lead" conversion scenario in marketing.

Aucta Pharmaceuticals

Series A in 2021
Aucta Pharmaceuticals is a pharmaceutical company that focuses on developing innovative therapeutics using the 505(b)(2) regulatory pathway. The company specializes in creating improved formulations from established molecules, with an emphasis on branded specialty products and niche generics. Aucta's primary therapeutic areas include central nervous system disorders, ophthalmics, and inhalation therapy. By leveraging advanced drug delivery technologies and a commitment to patient-centric solutions, Aucta aims to enhance treatment options for various conditions, particularly those affecting women and children. The company is dedicated to regularly bringing improved versions of proven medications to market, thereby addressing unmet medical needs and improving patient compliance.

Denovo Biopharma

Series D in 2020
Denovo Biopharma (Hangzhou) Co. Ltd, based in Hangzhou, China, is a privately held biotechnology company specializing in biopharmaceuticals. The company focuses on personalized drug development through a unique platform that enables de novo genomic biomarker discovery using archived clinical samples. This innovative technology is particularly beneficial for late-stage clinical drugs that have previously demonstrated unsatisfactory efficacy. By identifying biomarkers linked to patient responsiveness, Denovo Biopharma assists biotech and pharmaceutical companies in designing targeted clinical trials, which aim to enhance efficacy and reduce adverse effects. Their biomarker discovery capabilities extend across various therapeutic areas, including oncology, metabolic disorders, cardiology, immunology, and neurology.

3D Medicines

Series D in 2020
3D Medicines is a biopharmaceutical company focused on personalized cancer treatment. Utilizing individual genetic information, they develop tailored medicines to prevent, diagnose, and treat cancer more effectively and safely than traditional one-size-fits-all approaches. Their primary focus is on immuno-oncology drugs, aiming to prolong survival time and improve quality of life for cancer patients. Currently, all their revenue is generated from operations in China.

G-Wearables

Private Equity Round in 2019
G-Wearables is a tech start-up focused on fashionable and versatile electronic wearables.

Yimi Station

Series A in 2018
Yimi Station is a Shenzhen-based company specializing in food ordering and delivery services through its innovative application. The platform allows users to place orders conveniently and have their meals delivered to smart food boxes equipped with automatic temperature control, which can be accessed via QR codes. In addition to food delivery, Yimi Station offers food retail, catering, storage, and logistics services, focusing on modernizing the food industry through advanced technology. With nearly 20 years of experience in the sector, the company aims to enhance the dining experience by providing nutritious meals in office buildings and school settings, ensuring quick and easy access for students and workers. Yimi Station is recognized for its unique approach and continues to explore new opportunities in personalized dining, particularly in campus environments.

TCR Cure

Series A in 2018
Chongqing TCRCure Biotechnology Co., Ltd. is a Beijing-based company that specializes in the research, development, and industrialization of tumor immune cell therapies. The firm offers a range of products and services, including universal T cell receptor chimeric T cell therapy, individualized TCR tumor immune cell customization therapy, and CAR-T therapy. Additionally, TCRCure is involved in clinical immune monitoring and immunological efficacy assessment, as well as providing virus and carrier production for external technical services. The company emphasizes a streamlined approach to biotechnology development, focusing on high throughput antigen-specific TCR cloning, industry-scale virus production, T cell genetic engineering, and immune cell manufacturing.

Qingmu Apartment

Venture Round in 2018
Qingmu Apartment is a apartment brand operator.

Ulu

Seed Round in 2018
Ulu, established in 2014 and headquartered in Amsterdam, Netherlands, specializes in mobility-related applications and telematics solutions. The company offers a mobile app that facilitates customer interaction and navigation services for users, along with telematics devices that provide real-time vehicle data to optimize fleet management for businesses. Ulu serves a diverse range of clients, including mobility service providers, leasing companies, and dealerships, across Europe and China.

Avular

Venture Round in 2018
Avular, based in Eindhoven's innovative Strijp-T district, specializes in designing, engineering, and manufacturing professional Unmanned Aerial Vehicle (UAV) systems. Their platform integrates hardware modules, software tools, and documentation, empowering users to gather valuable data from aerial operations. The company's multi-disciplinary team, working in an open and collaborative environment, consistently pushes technological boundaries to deliver innovative drone solutions.

YUNSPACE

Series B in 2018
YunSpace is a Chinese company that operates an online platform for short-term commercial space rentals. Founded in 2012 and based in Shanghai, the platform connects organizations seeking venues for events with a diverse range of commercial real estate options. YunSpace offers various spaces, including exhibition halls, commercial plazas, art galleries, cultural blocks, cruise terminals, and stadiums, catering to a wide array of client needs. The company provides comprehensive solutions that encompass not only the rental of spaces but also the management and transaction processes, as well as cultural and creative intellectual property related to events. This makes YunSpace a valuable resource for clients looking to host activities in unique and differentiated environments.

ZooZ

Series C in 2016
Zooz is a technology company founded in 2010 that specializes in developing a payments platform aimed at enhancing the payment performance of merchants. The platform offers an integrated solution that includes acquirers, e-wallets, alternative payment methods, and fraud management services. By routing transactions through the entire payment process, Zooz enables businesses to optimize and streamline their payment operations within a complex ecosystem. In July 2018, Zooz was acquired by PayU, further expanding its capabilities and reach in the payments landscape.

ShareBang

Seed Round in 2016
ShareBang is a company that has developed an intelligent social marketing system designed to enhance marketing effectiveness for its clients. Its online platform facilitates the creation of marketing networks, providing businesses with streamlined access to their customers. By leveraging this technology, clients can implement more efficient marketing campaigns, ultimately improving their outreach and engagement with target audiences. ShareBang aims to optimize the marketing process through innovative solutions that connect businesses with their customers more effectively.

Yunzhou Intelligence Technology

Series B in 2016
Zhuhai Yunzhou Intelligence Technology Ltd. specializes in the manufacture and marketing of unmanned surface vehicles (USVs) designed for the water monitoring sector. Founded in 2010 and based in Zhuhai, China, the company offers a range of robotic water samplers and inspectors in various sizes, along with essential accessories such as handheld terminals, base stations, and outboard motors. Its products facilitate diverse applications, including routine and emergency water sampling, spatial distribution analysis of water quality factors, lake floor topographic surveying, pollution source tracking, and studies of lake and coastal waters. Yunzhou's technology also aids in predicting algae blooms, contributing to environmental monitoring efforts. The company distributes its products through a network of dealers worldwide.

Oase

Series A in 2015
Oase is a app, you connect from your device to our server and have access to a PC that runs everything in the best quality and performance.

baolaitong.com

Angel Round in 2015
Beijing Baolaitong Technology Co., Ltd., established in 2010 and headquartered in Beijing, China, specializes in providing internet technology services tailored to the medical industry. The company focuses on developing solutions for the pharmaceutical sector, including a distribution management system for off-hospital settings and an integrated patient assistance system. These offerings enable hospitals to efficiently manage various aspects of medical treatment, including medication distribution and patient payments, thereby enhancing operational effectiveness in healthcare delivery.

Science For Life

Series A in 2015
Science For Life offers telemedicine solutions and services. They work on product development, program design, project construction, technical support, and service operations in the field of telemedicine. Their solutions include two way referral, post-hospital follow-up, remote monitoring, mobile medical, and teleconsultation.

Oase

Seed Round in 2015
Oase is a app, you connect from your device to our server and have access to a PC that runs everything in the best quality and performance.

Sunointech

Series A in 2015
Sunointech is a mobile interactive marketing service provider based in China. The company specializes in creating innovative marketing solutions that engage users through mobile platforms. By leveraging advanced technology and data analytics, Sunointech aims to enhance brand visibility and drive consumer interaction, helping businesses effectively reach their target audiences in the competitive digital landscape.

72 Bian

Angel Round in 2014
72 Bian is an e-commerce platform for electronics and computer hardware products.

123haitao.com

Angel Round in 2014
123haitao.com is a content-sharing website for shopping experiences and information based on social sharing. is positioned in the sharing and exchange of overseas online shopping experiences, educating users on how to shop in overseas e-commerce, how to choose a shipping firm, and selecting preferable information from overseas e-commerce to make personal remarks on purchases.

Sunointech

Angel Round in 2014
Sunointech is a mobile interactive marketing service provider based in China. The company specializes in creating innovative marketing solutions that engage users through mobile platforms. By leveraging advanced technology and data analytics, Sunointech aims to enhance brand visibility and drive consumer interaction, helping businesses effectively reach their target audiences in the competitive digital landscape.

BeyondSpring

Series A in 2014
BeyondSpring Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company based in New York, specializing in the development of cancer therapies, particularly in immuno-oncology. Founded in 2013, the company’s primary asset is Plinabulin, which is undergoing late-stage clinical trials as an anti-cancer treatment in combination with docetaxel for advanced non-small cell lung cancer, aimed at preventing chemotherapy-induced neutropenia. BeyondSpring is also exploring Plinabulin’s potential in combination with various immuno-oncology agents, including therapies targeting programmed cell death protein 1 and CTLA-4, to treat multiple cancer types. In addition to its lead asset, the company is developing a range of small molecule immune agents in preclinical stages and has established a drug development platform utilizing the ubiquitin-mediated protein degradation pathway. BeyondSpring has formed collaborations with notable research institutions, including the Fred Hutchinson Cancer Research Center and the University of Washington, to advance its research and development efforts.

Shanghai Baison Software

Series C in 2014
Shanghai Baison Software Co., Ltd. is a Shanghai-based company established in 2000, specializing in the development of enterprise resource planning software tailored for the apparel, accessories, and home textile industries. The company offers comprehensive management systems for retail businesses, encompassing various sectors such as sports, furniture, cosmetics, beauty, jewelry, and food. Baison Software provides a range of services, including retail distribution, supply chain management, e-commerce solutions, mobile applications, and big data analytics. With a network of over 100 service agencies across China, the company supports the daily operations of more than 30 million physical stores and over 20,000 online shops. Baison Software is dedicated to facilitating the transformation and innovation of Chinese retailers, aiming to enhance brand value through advanced retail solutions and operational services.

Zannan

Series B in 2014
Zannan Technology is a fast-growing high-tech company focused on scientific and technological innovation, and it is dedicated to the research and development, production, and sale of high-performance catalysts and new polymer materials.

Yunzhou Intelligence Technology

Series A in 2014
Zhuhai Yunzhou Intelligence Technology Ltd. specializes in the manufacture and marketing of unmanned surface vehicles (USVs) designed for the water monitoring sector. Founded in 2010 and based in Zhuhai, China, the company offers a range of robotic water samplers and inspectors in various sizes, along with essential accessories such as handheld terminals, base stations, and outboard motors. Its products facilitate diverse applications, including routine and emergency water sampling, spatial distribution analysis of water quality factors, lake floor topographic surveying, pollution source tracking, and studies of lake and coastal waters. Yunzhou's technology also aids in predicting algae blooms, contributing to environmental monitoring efforts. The company distributes its products through a network of dealers worldwide.

HYGIA

Private Equity Round in 2013
HYGIA is a comprehensive enterprise integrating the design, manufacture, sales, installation, maintenance, and technical services of environmental protection sewage, sludge, and waste liquid treatment equipment.

Long Institute

Series A in 2013
Long Institute is a data research institute that focuses on big data services, providing data management, mining and services.

Tvmining

Series B in 2012
Tvmining is a Beijing-based company that specializes in developing media cloud computing services, online applications, and system technology solutions for the domestic broadcasting, television, and new media industry. Their focus is on providing innovative solutions to enhance the media landscape in China through cutting-edge technology and software development.

Miliyo

Private Equity Round in 2010
Miliyo is a dating platform. Miliyo is available for ios and android systems. They implement a video authentication mechanism to prevent fake photos. Through their mechanism that offers manual on duty patrols, user reports, and illegal keyword alerts, they eliminate illegal information and lock relevant users.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.